Clinical trial
Best Endovascular Versus Best Surgical Therapy in Patients With Critical Limb Ischemia
NCT02060630 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Best Endovascular Versus Best Surgical Therapy in Patients With Critical Limb Ischemia
- Lead sponsor
- Carelon Research
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2014
- Completion date
- March 1, 2022
- Enrollment
- 1,843 (actual)
- Sites
- 161
Conditions
As the registry lists them; a condition with its own page is linked.
critical limb ischemia